Oncolytic Viruses: ESMO 2023 Abstracts Analysis

The European Society for Medical Oncology (ESMO) Annual Congress was held between the 20th – 24th of October. The congress highlighted drug discoveries, unveiling potential new avenues in the oncolytic viruses space. From the data presented, our analysts carefully reviewed and pinpointed 11 abstracts relevant to oncolytic viruses.

Obtain the insights from ESMO 2023 in our latest infographic featuring concise abstract summaries and analysis relevant to oncolytic viruses.

Home > Infographic 2023 Oncolytic Viruses ESMO Abstracts Analysis

mRNA

This Infographic Includes:

- - Primary analysis covering the data types presented, diseases under
    investigation, and viral families.
  - A breakdown of 8 clinical and 3 preclinical abstracts from ESMO 2023.
  - Extensive abstract summaries on clinical trial outlines and preclinical abstract summaries.
Download Here

Find out more

Beacon is the essential decision-support tool for developers of complex therapeutics. Our market-defining, proprietary ontologies, combined with the most accurate and comprehensive life sciences data, provide our customers with unparalleled visibility of the drug and trial landscape.

With Beacon, you can make drug development decisions with confidence. This is why 23 of the world’s top 25 drug developers trust us.

Discover a database tailored to your needs

Speak with our Team

Our dedicated account and research teams can help you with questions by showing you how this insight and data is collated on Beacon.

Get Started